Updates and current challenges in microRNA research for personalized medicine in ovarian cancer

V Mandilaras, M Vernon… - Expert Opinion on …, 2017 - Taylor & Francis
Introduction: Ovarian cancer (OC) is the second most common and the most lethal of the
gynecological malignancies. Currently, there exists no effective screening tool for OC …

Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer

A Mahdian-Shakib, R Dorostkar, M Tat… - Biomedicine & …, 2016 - Elsevier
Ovarian cancer (OC) is the most lethal of malignant gynecological cancers, and has a very
poor prognosis, frequently, attributable to late diagnosis and responsiveness to …

[HTML][HTML] MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer

MK Pal, SP Jaiswar, VN Dwivedi… - Cancer biology & …, 2015 - ncbi.nlm.nih.gov
Epithelial ovarian cancer (EOC) is the leading cause of death among all gynecological
malignancies. Despite the technological and medical advances over the past four decades …

microRNAs as biomarkers of ovarian cancer

H Zhang, B Lu - Expert Review of Anticancer Therapy, 2020 - Taylor & Francis
Introduction: Ovarian carcinoma (OC) is the leading cause of death in women with
gynecologic cancers. Most patients are diagnosed at an advanced stage with a low five-year …

The clinical and diagnostic role of microRNAs in ovarian carcinoma

B Davidson, CG Tropé, R Reich - Gynecologic oncology, 2014 - Elsevier
Abstract Objective MicroRNAs (miRNAs, miRs) are non-coding RNAs which post-
transcriptionally regulate mRNA synthesis. Data regarding the expression and clinical …

Current status and implications of microRNAs in ovarian cancer diagnosis and therapy

MS Zaman, DM Maher, S Khan, M Jaggi… - Journal of ovarian …, 2012 - Springer
Ovarian cancer is the fifth most common cancer among women and causes more deaths
than any other type of female reproductive cancer. Currently, treatment of ovarian cancer is …

miRNAs and ovarian cancer: An overview

B Deb, A Uddin, S Chakraborty - Journal of cellular physiology, 2018 - Wiley Online Library
Ovarian cancer (OC) is the sixth most common cancer in women globally. However, even
with the advances in detection and therapeutics it still represents the most dangerous …

MicroRNA in ovarian cancer: biology, pathogenesis, and therapeutic opportunities

SN Chen, R Chang, LT Lin, CU Chern, HW Tsai… - International journal of …, 2019 - mdpi.com
Ovarian cancer comprises one of the three major malignant tumor types in the female
reproductive system. The mortality rate of this cancer is the highest among all gynecological …

MicroRNAs as biomarkers for early diagnosis, prognosis, and therapeutic targeting of ovarian cancer

Y Mirahmadi, R Nabavi, F Taheri… - Journal of …, 2021 - Wiley Online Library
Ovarian cancer is the major cause of gynecologic cancer‐related mortality. Regardless of
outstanding advances, which have been made for improving the prognosis, diagnosis, and …

Circulating and tissue microRNAs as biomarkers for ovarian cancer prognosis

SM Parizadeh, R Jafarzadeh-Esfehani… - Current Drug …, 2019 - ingentaconnect.com
Ovarian cancer (OC) is one of the most common cancers globally with a high rate of cancer-
associated mortality. OC may be classified into epithelial cell neoplasms, germ cell …